Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Schizophrenia

  Free Subscription


18.03.2024

1 Am J Med Genet B Neuropsychiatr Genet
2 Am J Psychiatry
3 Biol Psychiatry
1 J Clin Psychopharmacol
1 Neuropsychopharmacology
1 PLoS One
2 Psychol Med


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Med Genet B Neuropsychiatr Genet

  1. KENDLER KS, Justis V
    William Boven's 1915 thesis "Similarity and Mendelism in the heredity of dementia praecox and manic-depressive insanity".
    Am J Med Genet B Neuropsychiatr Genet. 2024;195:e32961.
    PubMed         Abstract available


    Am J Psychiatry

  2. VAN DER PLUIJM M, Wengler K, Reijers PN, Cassidy CM, et al
    Neuromelanin-Sensitive MRI as Candidate Marker for Treatment Resistance in First-Episode Schizophrenia.
    Am J Psychiatry. 2024 Mar 13:appiajp20220780. doi: 10.1176/appi.ajp.20220780.
    PubMed         Abstract available

  3. VITA A, Barlati S, Ceraso A, Nibbio G, et al
    Durability of Effects of Cognitive Remediation on Cognition and Psychosocial Functioning in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Am J Psychiatry. 2024 Mar 13:appiajp20230396. doi: 10.1176/appi.ajp.20230396.
    PubMed         Abstract available


    Biol Psychiatry

  4. KIM J, Park IH
    Identifying an Early Neuropathological Mechanism in Schizophrenia With Brain Organoids.
    Biol Psychiatry. 2024;95:608-610.
    PubMed        

  5. RADHAKRISHNAN R
    In Vivo Synaptic Density in Early Schizophrenia: Are There No Differences or Are They Too Small to Detect?
    Biol Psychiatry. 2024;95:605-607.
    PubMed        

  6. STEIN F, Gruber M, Mauritz M, Brosch K, et al
    Brain Structural Network Connectivity of Formal Thought Disorder Dimensions in Affective and Psychotic Disorders.
    Biol Psychiatry. 2024;95:629-638.
    PubMed         Abstract available


    J Clin Psychopharmacol

  7. KORKMAZ SA, Koca E, Yilmaz O, Ozbek T, et al
    Real-World Evidence of Antipsychotic Monotherapy Versus Polypharmacy in the Treatment of Schizophrenia Spectrum Disorders.
    J Clin Psychopharmacol. 2024 Mar 5. doi: 10.1097/JCP.0000000000001837.
    PubMed         Abstract available


    Neuropsychopharmacology

  8. HUANG AS, Kang K, Vandekar S, Rogers BP, et al
    Lifespan development of thalamic nuclei and characterizing thalamic nuclei abnormalities in schizophrenia using normative modeling.
    Neuropsychopharmacology. 2024 Mar 13. doi: 10.1038/s41386-024-01837.
    PubMed         Abstract available


    PLoS One

  9. FEIJS HME, van Aken L, van der Veld WM, van der Heijden PT, et al
    No relations between executive functions and dimensional models of psychopathology or is time the missing link?
    PLoS One. 2024;19:e0288386.
    PubMed         Abstract available


    Psychol Med

  10. MARCO-GARCIA S, Ariyo K, Owen GS, David AS, et al
    Decision making capacity for treatment in psychiatric inpatients: a systematic review and meta-analysis.
    Psychol Med. 2024;54:1074-1083.
    PubMed         Abstract available

  11. LAWRENCE JM, Breunig S, Foote IF, Tallis CB, et al
    Genomic SEM applied to explore etiological divergences in bipolar subtypes.
    Psychol Med. 2024;54:1152-1159.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.